Reduction of Stem Cell Collection Pheresis Time in Patients with Large Numbers of Circulating CD34+ with Upfront Plerixafor Use

Key Points

• Plerixafor significantly reduces stem cell collection time, enhancing patient experience and outcomes.
• Patients with elevated CD34+ counts saw a reduction to 4 hours in collection time, compared to standard methods.
• Analysis involves collection procedures and outcomes in patients undergoing stem cell pheresis with and without plerixafor.
• Enhanced collection efficiency may lead to better treatment timelines, with implications for therapy success.